Tag: facade
-
Novo plans larger study after encouraging semaglutide results
By Nikolaj Skydsgaard COPENHAGEN (Reuters) – Novo Nordisk's experimental injectable diabetes drug semaglutide reduced cardiovascular risk by 26 percent, according to results released on Friday, paving the way for a new and bigger study on the drug's benefits. Semaglutide is the third diabetes drug to show such heart benefits, after Novo's Victoza injectable and Eli…
-
Japan confronts disability stigma after silence over murder victims’ names
By Kwiyeon Ha and Linda Sieg TOKYO (Reuters) – The stabbing deaths of 19 disabled people in their sleep last July and the silence surrounding their identities are forcing Japan to grapple with its attitudes toward physically and cognitively impaired persons, less than four years before Tokyo hosts the Paralympics. Almost nothing except their genders…